This observation becomes important when we note that our study of cancer genes in the Results Section, highlighted a number of well known driver-genes (TP53, KRAS, BRAF, etc) together with long tails of infrequent drivers36 which are most likely unique to an individual tumour and patient. This evidence concerns the gene BRAF and neoplasm.